PMID: 1357461Oct 31, 1992Paper

Protective efficacy of a serogroup B meningococcal vaccine in Sao Paulo, Brazil

Lancet
J C de MoraesI M Gral

Abstract

Serogroup B Neisseria meningitidis is the most common cause of epidemic meningococcal disease in developed countries. Until recently no vaccine has been available for prevention of infection with this organism. In an attempt to control epidemic serogroup B meningococcal disease in greater Sao Paulo, Brazil, during 1989 and 1990, a Cuban-produced outer-membrane-protein-based serogroup B meningococcal vaccine was given to about 2.4 million children aged from 3 months to 6 years. We have done a case-control study to estimate the efficacy of the vaccine in greater Sao Paulo. Microbiologically confirmed cases of serogroup B meningococcal disease were identified through hospital-based surveillance. Controls were matched by neighbourhood and age. Vaccination status was confirmed by inspection of vaccination cards. Between June, 1990, and June, 1991, 112 patients and 409 matched controls with confirmed vaccine status were enrolled. Estimated vaccine efficacy varied by age: 48 months or older = 74% (95% Cl 16 to 92%), 24 to 47 months = 47% (-72 to 84%), and less than 24 months = -37% (< -100 to 73%). Our results suggest that the Cuban-produced vaccine may be effective for prevention of serogroup B meningococcal disease in older children...Continue Reading

References

Aug 1, 1991·The Journal of Infectious Diseases·R W PinnerC V Broome
Nov 21, 1991·The New England Journal of Medicine·C V Broome, R F Breiman
Jan 1, 1983·Reviews of Infectious Diseases·H Peltola
Feb 2, 2013·Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Médicas E Biológicas·G P SilvaL G Milagres

❮ Previous
Next ❯

Citations

Apr 17, 2013·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Alexandra Schubert-Unkmeir, Myron Christodoulides
Sep 1, 1996·FEMS Immunology and Medical Microbiology·M G DanelliC E Frasch
Oct 22, 2013·The Journal of Infection·Marion Roderick, Adam Finn
Aug 8, 2007·Transactions of the Royal Society of Tropical Medicine and Hygiene·Soraia M CordeiroAlbert I Ko
Jan 27, 2004·Vaccine·Carmen ArigitaGideon F A Kersten
Jun 5, 2003·International Journal for Parasitology·Guido Grandi
May 4, 2002·Lancet·Luis JódarDan M Granoff
Dec 12, 2001·Vaccine·S L Morley, A J Pollard
Jan 18, 2003·Vaccine·Sebastian KurzGuido Dietrich
Aug 8, 2001·The Journal of Emergency Medicine·D A JerrardG L Schindelheim
Apr 13, 1999·Infectious Disease Clinics of North America·H Ahmad, E K Chapnick
Sep 2, 1999·Infectious Disease Clinics of North America·H Peltola
Nov 7, 2000·FEMS Immunology and Medical Microbiology·M C BashC E Frasch
Oct 17, 2002·FEMS Immunology and Medical Microbiology·Clementien Vermont, Germie van den Dobbelsteen
Feb 16, 2013·Journal of Proteome Research·Bas van de WaterbeemdAd P J M de Jong
Feb 12, 1998·The New England Journal of Medicine·A SchuchatB A Perkins
Apr 23, 2010·The New England Journal of Medicine·Lionel K K TanRay Borrow
Feb 11, 2010·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Dan M Granoff
Nov 1, 1996·The Pediatric Infectious Disease Journal·E A KirschB P Giroir

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.